Paul D. Rubin, Senior VP Clinical Development & CMO at XOMA Corp (XOMA), sold 6,000 shares at $8.27 ($50K) on 2014-01-21, disclosed to the SEC on 2014-01-23.
Scheduled sale ($50k) by Senior VP Clinical Development & CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.27 | 306 | $3K | 5.1% |
| 2 | $8.27 | 5,694 | $47K | 94.9% |
| Total | $8.27 avg | 6,000 | $50K | 100% |
| Filing → |
| BIOA | SELL | 2026-02-03 | $139K | — | Filing → |
| BIOA | SELL | 2026-01-06 | $191K | — | Filing → |
| BIOA | SELL | 2025-12-11 | $216K | — | Filing → |